Genpact Files 8-K for Financial Results Release on Feb 8, 2024
Ticker: G · Form: 8-K · Filed: Feb 8, 2024 · CIK: 1398659
| Field | Detail |
|---|---|
| Company | Genpact LTD (G) |
| Form Type | 8-K |
| Filed Date | Feb 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: earnings, financial-results, 8-K, disclosure
TL;DR
**Genpact just dropped their financial results, time to check the numbers!**
AI Summary
Genpact LTD filed an 8-K on February 8, 2024, under Items 2.02 and 9.01, indicating the release of their financial results and related exhibits. This filing is a standard procedure for public companies to disclose their financial performance, which is crucial for investors to understand the company's health and future prospects. For shareholders, this means new financial data is available to assess Genpact's profitability and growth, directly impacting their investment decisions.
Why It Matters
This filing signals the release of Genpact's latest financial performance, providing critical data for investors to evaluate the company's operational health and make informed investment decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results, which is a standard and expected event for a public company.
Analyst Insight
A smart investor would review the full financial statements and exhibits referenced in this 8-K to understand Genpact's latest performance metrics, such as revenue, net income, and guidance, before making any investment decisions.
Key Numbers
- February 8, 2024 — Date of Report (Indicates when the earliest event reported in the filing occurred.)
- 001-33626 — Commission File Number (Unique identifier for Genpact LTD's filings with the SEC.)
- $0.01 — Par Value per Share (The nominal value assigned to each common share of Genpact LTD.)
Key Players & Entities
- Genpact LTD (company) — the registrant filing the 8-K
- February 8, 2024 (date) — the date of the earliest event reported and filing date
- 001-33626 (other) — Commission File Number for Genpact LTD
- G (other) — Trading Symbol for Genpact LTD on the New York Stock Exchange
- $0.01 (dollar_amount) — par value per common share
FAQ
What is the purpose of this 8-K filing by Genpact LTD?
This 8-K filing by Genpact LTD is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically under Item 2.02, 'Results of Operations and Financial Condition,' and Item 9.01, 'Financial Statements and Exhibits,' indicating the release of their financial results.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 8, 2024, which is also the date of the report.
What is Genpact LTD's trading symbol and on which exchange are its securities registered?
Genpact LTD's trading symbol is 'G', and its common shares, with a par value of $0.01 per share, are registered on the New York Stock Exchange.
What is the address of Genpact LTD's principal executive offices?
The address of Genpact LTD's principal executive offices is Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda.
Is Genpact LTD considered an emerging growth company according to this filing?
The filing indicates that Genpact LTD is NOT an emerging growth company, as the appropriate box for 'emerging growth company' is not checked.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-02-08 16:09:41
Key Financial Figures
- $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange I
Filing Documents
- g-20240208.htm (8-K) — 30KB
- genpactltdexhibit991q423.htm (EX-99.1) — 345KB
- imagea.jpg (GRAPHIC) — 11KB
- 0001398659-24-000025.txt ( ) — 541KB
- g-20240208.xsd (EX-101.SCH) — 2KB
- g-20240208_lab.xml (EX-101.LAB) — 24KB
- g-20240208_pre.xml (EX-101.PRE) — 13KB
- g-20240208_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 8, 2024, Genpact Limited (the "Company") issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023. The Company is furnishing this Form 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition." A copy of the press release, attached hereto as Exhibit 99.1 , is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in the press release and on the conference call. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press release dated February 8, 2024 Exhibit 104 C over Page Interactive Data File (embedded within the Inline XBRL document) Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENPACT LIMITED Date: February 8, 2024 By: /s/ Heather D. White Name: Heather D. White Title: Senior Vice President, Chief Legal Officer and Secretary